738P Strong tumour cytidine deaminase (CDA) staining predicts for improved survival associated with sequential nab-paclitaxel (nabP) and gemcitabine (GEM) chemotherapy as first line treatment of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC).